HedgeFund

Battea Class Action Services - Securities Class Action Industry Lookback And Observations

Battea Global Litigation Research



Battea Global Litigation Research

www.battea.com

[email protected]


Executive Summary


There has been incredible growth in securities and antitrust class action litigations and settlements, particularly as they have unfolded in 2017, 2018 and 2019. The number of new cases and new settlements from traditional securities litigation to antitrust rate rigging, spread inflation and other forms of collusion are at an all-time high and shows no signs of slowing down.


While billions of dollars have already settled in the Foreign Exchange Benchmark Antitrust manipulation case, and have distributed in the Petrobras U.S. ADR settlement, there are still several billions expected to settle in cases currently in litigation.


We are actively monitoring the Interest Rate Swaps Antitrust Litigation (Spread Manipulation), GSE Bonds Antitrust Litigation, and on the equity side of the horizon, American Realty Capital Properties and Valeant Pharmaceuticals International (which include settlement funds of $1.025 billion and $1.210 billion, respectively).


In 2020, as in 2019, we are going to see historical amounts of monies paid out to investors that traded in the domestic and international foreign exchange and derivatives markets.


As of January 31, 2020, Pending (and partial) settlements include:



Key Findings


In the last five years, the number of Federal securities class action filings has risen by more than 100% across the U.S. In 2019 alone, 428 new cases were filed, the highest number of filings in fifteen years.


Total filings include merger objection-related cases, which have increased significantly in federal courts over the past few years.

On the international front, there are hundreds of international investigations currently being monitored by the Battea Global Litigation Research team including, but not limited to, Australian, European, and Canadian FX manipulations, Danske Bank, Mexican Government Bonds, Petrobras, Volkswagen, and Westpac. Global Recoveries are expected to be in the billions for these cases.


With more than $15.7 billion in settlement funds available to eligible investors, and with the incredible growth in securities and antitrust class action litigations and settlements over the past five years, the industry will look to further bolster its success in the coming years.


However, these settlements, and the securities and financial products that are eligible to participate, are extremely complex and many claimants will struggle asserting their claims. Those who file successful claims stand to receive significant or even outsized recovery awards.


Due to the complexity associated with determining the transactions that are eligible to participate in these multiple settlements, and the large recovery amounts available to the eligible claimants, we are requesting that you provide all your relevant transaction data to Battea for a no-cost analysis.









Q1 2020 Update & Beyond


In Q1 2020, there were 98 filings announced, a slight decline when compared to Q1 2019 (118). This decline could be attributed to the COVID-19 pandemic. Should the industry surpass 400 filings in 2020, it would be for the fourth year in a row (2017: 412, 2018: 403, 2019: 428). Most of the filings in 2020 will be coming from the Health Technology, Electronic Services, and Finance sectors.


There have been five major securities class actions tied to the COVID-19 pandemic: Norwegian Cruise Lines, Inovio Pharmaceuticals, Zoom, Phoenix Tree Holdings, and SCWorx Corp. Allegations in these COVID-19-related cases include unfair sales practices (Norwegian Cruise Lines – filed March 12th), mislead reports of a possible COVID-19 vaccine (Inovio Pharmaceuticals – filed March 12th), privacy and security concerns (Zoom – filed April 7th), an IPO offering related to residential real estate in China (Phoenix Tree Holdings – filed April 29th).


In 2020 and the years to come, we are going to see historical amounts of monies paid out to investors that traded in the domestic and international foreign exchange and derivatives markets.


Billions of dollars have already settled in the foreign exchange antitrust manipulation cases and some of the derivatives cases, and at least another $10 billion dollars is expected to settle in several derivative cases currently in litigation with more expected litigation on the horizon.



Find Out More and Verify Your Eligibility to File


As there are such significant sums available to damaged investors, it is crucial to take timely action to establish a claim. A vast majority of international filings require eligible investors to opt-in, which demands an unparalleled understanding of the filing process, and an expert firm to decipher the specifics of each case and the various recovery options available.


To maximize recovery potential, it is highly recommended to submit ALL your transactional data to Battea who can in turn provide the transparency required to validate your eligibility and maximize your recoveries. Do not risk leaving large sums of money behind by failing to act.





Battea Global Litigation Research
www.battea.com
[email protected]


46 Southfield Avenue, Suite 450
Stamford, CT 06902
(203) 987-4949

Pilestraede 6
Third Floor
1112 Copenhagen K
Denmark



Send The Author A Message
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

You May Also Enjoy The Following Posts
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.